GRAMPIAN PRIVATE UROLOGICAL SERVICES LIMITED

💤Zombieactive
SC744215 · ltd · incorporated 2022-09-12
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Sept 2024
Net worth
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Hospital activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: active trading company with strong profile and acceptable with review structure.

Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (76/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (1 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
8 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Sept 2023Sept 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-09-302023-09-30

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (9 events)Click to expand
  1. 2025-05-23
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-03-24
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  3. 2024-05-06
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  4. 2024-03-20
    NESHAT MOKADEM, Alexandra Leila resigned
    director
  5. 2024-01-08
    NESHAT MOKADEM, Alexandra Leila appointed
    director
  6. 2024-01-08
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  7. 2022-09-12
    🏢
    Company incorporated
    As GRAMPIAN PRIVATE UROLOGICAL SERVICES LIMITED
  8. 2022-09-12
    MOKADEM, Ismail, Dr appointed
    director
  9. 2022-09-12
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

75/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Dr Ismail Mokadem
Individual · British · DOB 01/1979 · age 47
5075%
50–75%board control50-75% shares · 50-75% voting · board control12/09/2022
Mrs Alexandra Leila Neshat Mokadem
Individual · British · DOB 03/1980 · age 46
2550%
25–50%board control25-50% shares · 25-50% voting · board control12/09/2022

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · AB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
CTEV INITIATIVE LIMITED
SC704847 · est 2021 · no financials extracted
4y
DYNAMIC THERAPY COLLECTIVE LTD
SC743999 · est 2022 · no financials extracted
3y
FAT FIVES FOOTBALL LTD
SC767628 · est 2023 · no financials extracted
2y
FEEL GROUP PURE OXYGEN LTD
SC835777 · est 2025 · no financials extracted
1y
FILIPE RIBEIRO LIMITED
SC377161 · est 2010 · no financials extracted
15y
FTSIG LIMITED
SC882939 · est 2026 · no financials extracted
GCW CARE LTD
SC781778 · est 2023 · no financials extracted
2y
GEORGE CROOKS CONSULTING LTD
SC553799 · est 2017 · no financials extracted
9y
GRANITE OCCUPATIONAL HEALTH LTD
SC565601 · est 2017 · no financials extracted
8y
GREENVIEW ORTHOPAEDICS LTD
SC752972 · est 2022 · no financials extracted
3y
HAVEN PSYCHOLOGY SERVICES LTD
SC844946 · est 2025 · no financials extracted
1y
HAWTHORN THERAPIES
SC883173 · est 2026 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2022-09-12
Jurisdictionscotland
Primary SIC86101 — Hospital activities

Registered office

10 Baillieswells Drive
Bieldside
Aberdeen
AB15 9AS
Scotland

Filing status

Accounts
Next due: 2026-06-30
Last made up to: 2024-09-30
Confirmation statement
Next due: 2026-09-25
Last: 2025-09-11

Officers (1 active · 1 resigned)

MOKADEM, Ismail, Dr
director · ~47y · appointed 2022-09-12
View their other companies + combined net worth →
Active
NESHAT MOKADEM, Alexandra Leila
director · ~46y · appointed 2024-01-08 · resigned 2024-03-20
Resigned

Click a director name to see their full track record across all companies.

Recent filings (8 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-09-11
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-05-23
termination-director-company-with-name-termination-date
officers · TM01
2025-03-24
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-09-24
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-05-06
appoint-person-director-company-with-name-date
officers · AP01
2024-01-08
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-09-16
incorporation-company
incorporation · NEWINC
2022-09-12